Close Menu

NEW YORK – Lexogen announced Wednesday it has received funding from the Austrian government to develop an RNA sequencing-based COVID-19 diagnostic test for mass screening.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.